$BIO Poor BIO liquidity, mainly due to “small market cap + concentrated chips + long unlock cycle + weak market making + weak fundamentals,” with high control by market makers/whales being the core reason.



## 1. The 5 main causes of poor BIO liquidity

### 1) Highly concentrated chips (most critical)

- Total supply is 3.32 billion tokens; circulating supply is about 1.87 billion tokens (56%), with 44% (about 1.45 billion) still locked.

- Allocation: 21.2% to the team, 17.8% to early investors, 25% to the ecosystem—together, 64% is held by the project party/private placements.

- The top 10 on-chain addresses are often tightly controlled, holding 50%+ of the circulating supply, meaning there is very little truly free-floating circulating supply.

### 2) Small market cap, shallow depth

- Market cap is only $100–300 million (mainstream coins are at the trillion level), so a few thousand dollars can be enough to dump or pump the price.

- Exchange bid-ask spread is 5%–15%, with large slippage; buying/selling $10,000–$20,000 can cause price to move 10%+.

### 3) Long unlock cycle, sell pressure is controllable

- Tokens for the team/investors are linearly unlocked over 3–6 years. In the early stage, circulation is low, so market makers can easily control the market.

- A large amount of tokens is staked (about 125 million tokens), further reducing circulating supply.

### 4) Market makers are absent; real liquidity is insufficient

- Only small exchanges have listed it, with no leading professional market makers (e.g., Wintermute).

- Most of the “market making” comes from the project team/market makers themselves—wash trading, volume spoofing, and matched trades—resulting in a lot of fake liquidity.

### 5) Weak fundamentals; no real demand

- The DeSci (decentralized science) track is still early, with few users and weak real-world implementation.

- The price is driven by news/narratives; the community is mainly retail, and there is little long-term capital.

## 2. Is it that “all the coins are in the hands of market makers”?

Yes, there is heavy control, but not 100%:

- Core control: the project team + early VCs + whales hold 60%–70% of the chips, tightly controlling the circulating supply.

- Few retail chips: only 30%–40% are in the hands of retail/secondary-market investors, which does not change the overall control setup.

- Typical controlled-price movement: a rapid rise on low volume, then consolidation at high levels, followed by a sudden dump—matching the “accumulate—pump—distribute (sell)—dump” pattern.

## 3. Risk reminders

- High slippage, hard to execute: large buys/sells can easily lose 10%–30%.

- Very prone to collapse/exit scams: market makers can dump and exit at any time, and the tokens can go to zero.

- A pure capital game: no real value—retail investors will inevitably lose in the long run. $
BIO61.09%
View Original
post-image
post-image
post-image
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin